Diabetes, Metabolic Syndrome, and Obesity in Relation to Serum Dioxin Concentrations: The Seveso Women’s Health Study
Author(s) -
Marcella Warner,
Paolo Mocarelli,
Paolo Brambilla,
Amelia K. Wesselink,
Steven J. Samuels,
Stefano Signorini,
Brenda Eskenazi
Publication year - 2013
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.1206113
Subject(s) - medicine , metabolic syndrome , obesity , glycated hemoglobin , hazard ratio , diabetes mellitus , body mass index , odds ratio , endocrinology , cohort , cohort study , physiology , type 2 diabetes , confidence interval
In animal studies, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters glucose transport and increases serum lipid levels and blood pressure. Epidemiologic evidence suggests an association between TCDD and metabolic disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom